Ad hoc Announcement according to Art. 17 Market Abuse Regulation

QIAGEN to conduct an up to $200 million share repurchase program Venlo, The Netherlands, January 31, 2018 – QIAGEN N.V. announces that its Managing Board, upon authorization of the Supervisory Board, has passed a resolution to exercise the authorization granted by the General Meeting of Shareholders on June 21, 2017, and to purchase shares in the... Read more

Sphere Fluidics expands Cyto-Mine sales team and distribution in US, Europe and Asia.

Cambridge, UK, 30 January 2018: Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, has today announced the expansion of its international commercial operations. The Company is expanding its direct sales and support activity in North America, having recently opened a sales and support operation in New Jersey, and has... Read more

Honeywell Announces Results Of The Private Exchange Offer For Its 3.812% Notes Due 2047

MORRIS PLAINS, N.J., Jan. 30, 2018 /PRNewswire/ — Honeywell International Inc. (“Honeywell” or the “Company”) (NYSE: HON) today announced the results of its exchange offer for any and all of its outstanding 3.812% Notes due 2047 (the “Original Notes”) issued by the Company for an equal principal amount of its new 3.812% Notes due 2047 (the “Exchange Notes”).... Read more

Takara Bio to Establish a New Facility for the Research and Manufacturing of Regenerative Medical Products

2018/02/19 January 30, 2018 – Takara Bio’s Board of Directors resolved today to establish a new facility for the research and manufacturing of regenerative medical products in coordination with the expansion of existing research and manufacturing facilities at the company’s head office site in Kusatsu, Shiga. Total project cost is expected to be around 7.3... Read more

SCIEX Launches New C100 Biologics Analyzer for High Throughput Glycan Screening

Solution offers researchers the power to perform glycan screening of large sample cohorts enabling better decisions in clone selection and cell culture optimization January 30, 2018 Framingham, MA — SCIEX, a global leader in life science analytical technologies, today announced the launch of the new C100HT for qualitative glycan screening in biopharma. Combined with SCIEX’s award-winning... Read more

Waters New ACQUITY Arc Bio System Brings Advanced Method Transfer Capabilities to Routine Bioseparations

The Waters ACQUITY Arc Bio System is an iron-free, bio-inert, quaternary liquid chromatograph specifically engineered to enable the efficient transfer and improvement of bioseparation analytical methods regardless of the LC platform on which the original method was developed. (Photo: Business Wire) January 30, 2018 08:30 AM Eastern Standard Time MILFORD, Mass.–(BUSINESS WIRE)–Waters Corporation (NYSE:WAT) today... Read more

Shimadzu’s New Nexera Mikros, a Micro Flowrate Compatible Liquid Chromatograph Mass Spectrometer, Provides the Pharmaceutical Industry with High Sensitivity, Durability, and Ease of Use

January 29, 2018 Shimadzu Corporation has released the Nexera Mikros, a micro flowrate-compatible liquid chromatograph mass spectrometer. The Nexera Mikros maintains the durability and operability of liquid chromatography mass spectrometry (LC-MS) systems while providing at least ten times the sensitivity. In recent years, in the field of pharmaceutical development, analysis has occasionally been performed on... Read more

Waters BioResolve RP mAb Polyphenyl Columns, Setting a New Standard for Reversed-Phase Separations of Monoclonal Antibodies and Antibody Drug Conjugates

Waters’ new BioResolve RP mAb Polyphenyl Columns are for the analysis of intact or sub-unit-digested monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) by reversed phase liquid chromatography (LC) and LC-mass spectrometry. (Photo: Business Wire) January 29, 2018 01:00 PM Eastern Standard Time MILFORD, Mass.–(BUSINESS WIRE)–Waters Corporation (NYSE:WAT) today introduced BioResolve™ RP mAb Polyphenyl 450 angstrom 2.7... Read more